PARTNERSHIPS
Dreavent's model is built on the conviction that connecting scientific ecosystems to global pharma markets requires more than capital — it requires the right institutional relationships, clinical execution infrastructure, and technology. Each of Dreavent's strategic partners plays a distinct and essential role in making that connection real.
Richi Foundation
The Richi Foundation is the institutional bridge that made the Spain–Boston connection possible. Founded by Ricardo García — Co-founder & CEO of Oncoheroes Biosciences — the Foundation has spent more than a decade building cross-sector relationships that connect capital, innovation, and global ecosystems. Its role in structuring the bilateral framework between Spain and Massachusetts was instrumental in enabling the launch of Dreavent's first fund.
Syneos Health
Syneos Health is the world's third largest clinical development organization, with 25,000 professionals across 100+ countries. Syneos Health experts are embedded within Dreavent's Boston Development Platform, providing each selected asset with the clinical expertise, regulatory knowledge, and site access the FDA development pathway requires — from IND submission through Phase 1 execution.
C10labs
C10 Labs is a Cambridge-based AI venture studio and fund dedicated to building AI-first companies at the intersection of artificial intelligence and life sciences. C10 Labs is Dreavent's strategic partner in the development of the Dreavent Engine — bringing proven AI commercialization methodology and deep technical expertise to Dreavent's proprietary investment intelligence system.